FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053703910> ?p ?o ?g. }

• W2053703910 endingPage "548" @default.
• W2053703910 startingPage "543" @default.
• W2053703910 abstract "Background. Docetaxel (DTX) and zoledronic acid (ZOL) are effective in patients with hormone resistant prostate cancer (HRPC) with bone metastases. A phase I clinical trial of metronomic administration of Zoledronic Acid ANd TaxoterE combination (ZANTE trial) in 2 different sequences was conducted in HRPC. Patients and methods. Twenty-two patients enrolled into the study (median age: 73 years; range: 43-80) received one of three escalated doses of DTX (30, 40 and 50mg/m2) in combination with a fixed dose of ZOL (2mg), both administered every 14 days in two different sequences: DTX at the day 1 followed by ZOL at the day 2 (sequence A) or the reverse (sequence B). Patients were evaluated for adverse events and serum IL-8, MMP-2 and MMP-9 were evaluated prior and after therapy with the two sequences of administration of DTX and ZOL. Results. The maximum tolerated dose was not achieved with sequence A. Two patients at third level of sequence B developed dose limiting toxicity. A disease control was obtained in six out of nine patients treated with sequence A, where a decrease of biological markers and PSA were also observed. No evidence of anti-tumor activity was observed in patients treated with sequence B. Conclusions. The bi-weekly combination of DTX (50mg/m2) followed by ZOL was feasible and show promising anti-tumor activity." @default.
• W2053703910 created "2016-06-24" @default.
• W2053703910 creator A5000970243 @default.
• W2053703910 creator A5001400787 @default.
• W2053703910 creator A5035710316 @default.
• W2053703910 creator A5048909242 @default.
• W2053703910 creator A5051933262 @default.
• W2053703910 creator A5055084999 @default.
• W2053703910 creator A5055183199 @default.
• W2053703910 creator A5062149201 @default.
• W2053703910 creator A5062511998 @default.
• W2053703910 creator A5064695597 @default.
• W2053703910 creator A5066976468 @default.
• W2053703910 creator A5072545598 @default.
• W2053703910 creator A5073891277 @default.
• W2053703910 creator A5074752423 @default.
• W2053703910 creator A5079443706 @default.
• W2053703910 creator A5082306007 @default.
• W2053703910 creator A5085015375 @default.
• W2053703910 creator A5085096826 @default.
• W2053703910 date "2010-09-15" @default.
• W2053703910 modified "2023-09-26" @default.
• W2053703910 title "Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial" @default.
• W2053703910 doi "https://doi.org/10.4161/cbt.10.6.12611" @default.
• W2053703910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20657175" @default.
• W2053703910 hasPublicationYear "2010" @default.
• W2053703910 type Work @default.
• W2053703910 sameAs 2053703910 @default.
• W2053703910 citedByCount "43" @default.
• W2053703910 countsByYear W20537039102012 @default.
• W2053703910 countsByYear W20537039102013 @default.
• W2053703910 countsByYear W20537039102014 @default.
• W2053703910 countsByYear W20537039102015 @default.
• W2053703910 countsByYear W20537039102016 @default.
• W2053703910 countsByYear W20537039102017 @default.
• W2053703910 countsByYear W20537039102018 @default.
• W2053703910 countsByYear W20537039102019 @default.
• W2053703910 countsByYear W20537039102020 @default.
• W2053703910 countsByYear W20537039102021 @default.
• W2053703910 crossrefType "journal-article" @default.
• W2053703910 hasAuthorship W2053703910A5000970243 @default.
• W2053703910 hasAuthorship W2053703910A5001400787 @default.
• W2053703910 hasAuthorship W2053703910A5035710316 @default.
• W2053703910 hasAuthorship W2053703910A5048909242 @default.
• W2053703910 hasAuthorship W2053703910A5051933262 @default.
• W2053703910 hasAuthorship W2053703910A5055084999 @default.
• W2053703910 hasAuthorship W2053703910A5055183199 @default.
• W2053703910 hasAuthorship W2053703910A5062149201 @default.
• W2053703910 hasAuthorship W2053703910A5062511998 @default.
• W2053703910 hasAuthorship W2053703910A5064695597 @default.
• W2053703910 hasAuthorship W2053703910A5066976468 @default.
• W2053703910 hasAuthorship W2053703910A5072545598 @default.
• W2053703910 hasAuthorship W2053703910A5073891277 @default.
• W2053703910 hasAuthorship W2053703910A5074752423 @default.
• W2053703910 hasAuthorship W2053703910A5079443706 @default.
• W2053703910 hasAuthorship W2053703910A5082306007 @default.
• W2053703910 hasAuthorship W2053703910A5085015375 @default.
• W2053703910 hasAuthorship W2053703910A5085096826 @default.
• W2053703910 hasBestOaLocation W20537039101 @default.
• W2053703910 hasConcept C121608353 @default.
• W2053703910 hasConcept C126322002 @default.
• W2053703910 hasConcept C126894567 @default.
• W2053703910 hasConcept C143998085 @default.
• W2053703910 hasConcept C197934379 @default.
• W2053703910 hasConcept C2776326535 @default.
• W2053703910 hasConcept C2780192828 @default.
• W2053703910 hasConcept C2781190966 @default.
• W2053703910 hasConcept C29730261 @default.
• W2053703910 hasConcept C71924100 @default.
• W2053703910 hasConcept C90924648 @default.
• W2053703910 hasConcept C98274493 @default.
• W2053703910 hasConceptScore W2053703910C121608353 @default.
• W2053703910 hasConceptScore W2053703910C126322002 @default.
• W2053703910 hasConceptScore W2053703910C126894567 @default.
• W2053703910 hasConceptScore W2053703910C143998085 @default.
• W2053703910 hasConceptScore W2053703910C197934379 @default.
• W2053703910 hasConceptScore W2053703910C2776326535 @default.
• W2053703910 hasConceptScore W2053703910C2780192828 @default.
• W2053703910 hasConceptScore W2053703910C2781190966 @default.
• W2053703910 hasConceptScore W2053703910C29730261 @default.
• W2053703910 hasConceptScore W2053703910C71924100 @default.
• W2053703910 hasConceptScore W2053703910C90924648 @default.
• W2053703910 hasConceptScore W2053703910C98274493 @default.
• W2053703910 hasIssue "6" @default.
• W2053703910 hasLocation W20537039101 @default.
• W2053703910 hasLocation W20537039102 @default.
• W2053703910 hasOpenAccess W2053703910 @default.
• W2053703910 hasPrimaryLocation W20537039101 @default.
• W2053703910 hasRelatedWork W2010765098 @default.
• W2053703910 hasRelatedWork W2060708716 @default.
• W2053703910 hasRelatedWork W2076831756 @default.
• W2053703910 hasRelatedWork W2094570582 @default.
• W2053703910 hasRelatedWork W2135620818 @default.
• W2053703910 hasRelatedWork W2155169688 @default.
• W2053703910 hasRelatedWork W2407641156 @default.
• W2053703910 hasRelatedWork W2588988563 @default.
• W2053703910 hasRelatedWork W2735900144 @default.
• W2053703910 hasRelatedWork W2770702948 @default.

• next